ENTEROCOLITIS FUNGAL

ENTEROCOLITIS FUNGAL was reported 30 times

ENTEROCOLITIS FUNGAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 6 0.0013
1 Vitamin D3 Analog [EPC] 3 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Polyene Antifungal [EPC] 2 0.0000
4 Antimetabolite Immunosuppressant [EPC] 1 0.0000
5 Glycopeptide Antibacterial [EPC] 2 0.0000
6 Antirheumatic Agent [EPC] 3 0.0000
7 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
8 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
9 BCL-2 Inhibitor [EPC] 1 0.0000
10 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
11 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
12 Nitroimidazole Antimicrobial [EPC] 1 0.0000
13 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
14 Corticosteroid [EPC] 18 0.0000
15 Azole Antifungal [EPC] 2 0.0000
16 5-alpha Reductase Inhibitor [EPC] 1 0.0000
17 Kinase Inhibitor [EPC] 5 0.0000
18 Alkylating Drug [EPC] 2 0.0000
19 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
20 alpha-Adrenergic Blocker [EPC] 1 0.0000
21 Insulin Analog [EPC] 3 0.0000
22 Loop Diuretic [EPC] 3 0.0000
23 Opioid Agonist [EPC] 1 0.0000
24 Factor Xa Inhibitor [EPC] 1 0.0000
25 Progestin [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 2 0.0000
27 Osmotic Laxative [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
31 Thalidomide Analog [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000